First Trust Advisors’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $2.85M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $404K | Sell |
|
|||||
|
2023
Q2 | $5.41M | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $254K | Sell |
|
|||||
|
2022
Q3 | $4.02M | Buy |
|
|||||
|
2022
Q2 | $524K | Buy |
|
|||||
|
2022
Q1 | $526K | Buy |
|
|||||
|
2021
Q4 | $517K | Sell |
|
|||||
|
2021
Q3 | $4.73M | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.77M | Sell |
|
|||||
|
2020
Q4 | $9.95M | Sell |
|
|||||
|
2020
Q3 | $5.55M | Sell |
|
|||||
|
2020
Q2 | $5.1M | Sell |
|
|||||
|
2020
Q1 | $3.87M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $987K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $889K | Sell |
|
|||||
|
2018
Q4 | $968K | Sell |
|
|||||
|
2018
Q3 | $4.14M | Buy |
|
|||||
|
2018
Q2 | $5M | Buy |
|